Cervical cancer control: a study of morbidity and mortality trends over a twenty-one-year period
- PMID: 953973
- DOI: 10.1002/1097-0142(197609)38:3<1357::aid-cncr2820380340>3.0.co;2-a
Cervical cancer control: a study of morbidity and mortality trends over a twenty-one-year period
Abstract
Data from a 21-year period are presented to evaluate the effects of a mass cytologic screening program on uterine cancer morbidity and mortality in Louisville, Jefferson County, Kentucky. The success of screening was greatest in the younger age groups. There was a fall-off after age 45 years, especially in those age 60 years or older. Women at highest risk for cervical cancer, in the low socioeconomic quartile, had a better initial screening rate than the two middle-income quartiles, and had the highest rate of all women for subsequent rescreening. The greatest decrease in both morbidity and mortality was in women under the age of 50 years. Women age 30-39 and 50-59 years benefitted the most, as measured by mortality, with a decrease of 70.8 and 69.0%, respectively. There was no change in mortality rates for those age 70 years or older. Although the average annual age-adjusted rate increased from 13.2 to 15.3/100,000 women over the 21-year period.
Similar articles
-
Trends in mortality from uterine cancer in relation to mass screening.Acta Cytol. 1977 Jan-Feb;21(1):5-9. Acta Cytol. 1977. PMID: 264759
-
The changing trends of uterine cancer and cytology: a study of morbidity and mortality trends over a twenty year period.Cancer. 1978 Nov;42(5):2439-49. doi: 10.1002/1097-0142(197811)42:5<2439::aid-cncr2820420546>3.0.co;2-d. Cancer. 1978. PMID: 719621
-
Trends in incidence of and mortality from invasive cancer of the uterine cervix in Scotland (1975-1994).Public Health. 1998 Nov;112(6):373-8. Public Health. 1998. PMID: 9883033
-
[Problem of uterine and ovarian cancer mass screening].Gan To Kagaku Ryoho. 2002 Nov;29(11):1907-16. Gan To Kagaku Ryoho. 2002. PMID: 12465389 Review. Japanese.
-
Cervical cancer.Cancer Surv. 1994;19-20:265-85. Cancer Surv. 1994. PMID: 7534630 Review.
Cited by
-
Efficacy of cervical cancer screening.Med Oncol Tumor Pharmacother. 1991;8(3):175-81. doi: 10.1007/BF02987177. Med Oncol Tumor Pharmacother. 1991. PMID: 1803178 Review.
-
Suivi des cytologies cervicales anormales dans une unité de médecine familiale.Can Fam Physician. 1991 Apr;37:863-7. Can Fam Physician. 1991. PMID: 21229065 Free PMC article.
-
Feasibility and acceptability of an HPV self-testing strategy: lessons from a research context to assess for ability to implement into primary care at a national level in Botswana.Front Glob Womens Health. 2024 Jan 8;4:1300788. doi: 10.3389/fgwh.2023.1300788. eCollection 2023. Front Glob Womens Health. 2024. PMID: 38259634 Free PMC article.
-
Knowledge of Saudi female university students regarding cervical cancer and acceptance of the human papilloma virus vaccine.Saudi Med J. 2014 Oct;35(10):1223-30. Saudi Med J. 2014. PMID: 25316467 Free PMC article.
-
Associations between risk-perception, self-efficacy and vaccine response-efficacy and parent/guardian decision-making regarding adolescent HPV vaccination.Papillomavirus Res. 2020 Dec;10:100204. doi: 10.1016/j.pvr.2020.100204. Epub 2020 Aug 1. Papillomavirus Res. 2020. PMID: 32750429 Free PMC article.